Percentage of CD19<sup>+</sup> Cells in Peripheral Blood Lymphocytes After Rituximab-Based Desensitization as a Predictor of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

Hirose, T; Iwami, D; Hotta, K; Sasaki, H; Higuchi, H; Shinohara, N

Percentage of CD19⁺ Cells in Peripheral Blood Lymphocytes After Rituximab-Based Desensitization as a Predictor of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

Hirose, T; Iwami, D; Hotta, K; Sasaki, H; Higuchi, H; Shinohara, N.

Afiliação

Hirose T; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Iwami D; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Electronic address: iwamidaiki@ybb.ne.jp.
Hotta K; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Sasaki H; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Higuchi H; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Shinohara N; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Transplant Proc ; 51(5): 1382-1386, 2019 Jun.

Article em En | MEDLINE | ID: mdl-31027828

Assuntos

Antígenos CD19/sangue; Incompatibilidade de Grupos Sanguíneos/tratamento farmacológico; Rejeição de Enxerto/prevenção & controle; Transplante de Rim/métodos; Rituximab/administração & dosagem; Adulto; Feminino; Rejeição de Enxerto/sangue; Rejeição de Enxerto/imunologia; Humanos; Imunoglobulinas Intravenosas/uso terapêutico; Incidência; Linfócitos/imunologia; Masculino; Pessoa de Meia-Idade; Plasmaferese/métodos; Estudos Retrospectivos; Transplantados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Incompatibilidade de Grupos Sanguíneos / Transplante de Rim / Antígenos CD19 / Rituximab / Rejeição de Enxerto Tipo de estudo: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transplant Proc Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google